| MR编号 | AT/H/0639/001 |
|---|
| 药品名称 | Linezolid Krka 2 mg/ml Infusionslösung |
|---|
| 活性成分 | |
|---|
| 剂型 | Solution for infusion |
|---|
| 上市许可持有人 | Krka, d. d., Novo mesto, Smarjeska cesta 6, 8501 Novo mesto, Slowenien |
|---|
| 参考成员国 - 产品名称 | Austria (AT) Linezolid Krka 2 mg/ml - Infusionslösung |
|---|
| 互认成员国 - 产品名称 | - Germany (DE)
Linezolid TAD 2 mg/ml Infusionslösung - United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Italy (IT)
- Poland (PL)
Linezolid Krka - Latvia (LV)
Linezolid Krka 2 mg/ml šķīdums infūzijām - Lithuania (LT)
Linezolid Krka 2 mg/ml infuzinis tirpalas - Estonia (EE)
LINEZOLID KRKA - Hungary (HU)
LINEZOLID KRKA 2 mg/ml oldatos infúzió - Bulgaria (BG)
- Czechia (CZ)
Linezolid Krka 2 mg/ml - Romania (RO)
- Slovakia (SK)
Linezolid Krka 2 mg/ml infúzny roztok - Slovenia (SI)
Linezolid Krka 2 mg/ml raztopina za infundiranje - Croatia (HR)
Linezolid Krka 2 mg/ml otopina za infuziju
|
|---|
| 许可日期 | 2016/10/25 |
|---|
| 最近更新日期 | 2025/05/30 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|